期刊文献+

PTEN对K562细胞mTOR调控的研究 被引量:6

Regulatory effects of PTEN gene on mTOR signaling pathway in K562 cell line
下载PDF
导出
摘要 目的:探讨肿瘤抑制基因PTEN在人慢性粒细胞白血病细胞株K562中对哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)的调控作用,以及雷帕霉素(rapamycin,RAPA)对K562细胞增殖抑制的影响。方法:通过实时荧光定量PCR(real-time fluorescent quantification PCR,RFQ-PCR)法检测甲磺酸伊马替尼(imatinib mexylate)干预K562细胞后BCR/ABL、PTEN、mTOR mRNA的表达水平及相互关系;Western印迹法检测甲磺酸伊马替尼干预和以腺病毒为载体感染野生型PTEN(Ad-PTEN-GFP)后K562细胞PTEN、Akt和p-Akt的蛋白表达水平;用MTT和FCM方法检测RAPA对不同腺病毒感染组K562细胞增殖及凋亡的影响。结果:格列卫干预K562细胞后,BCR/ABL和mTOR mRNA表达下调,PTEN mRNA表达上调;与感染Ad-GFP组相比,感染Ad-PTEN-GFP组的mTOR mRNA表达下调;Ad-PTEN-GFP感染与10nmol/L RAPA联合作用于K562细胞能够发挥协同作用,对K562细胞的增殖抑制率明显高于单独作用组。结论:PTEN是mTOR的上游调控基因,能够抑制mTOR的表达。RAPA与野生型PTEN一起可以协同抑制K562细胞的增殖。 Objective : To investigate the regulatory effects of tumor-suppressing gene PTEN on mammalian target of rapamycin (mTOR) signaling pathway in human chronic myeloid leukemia (CML) K562 cells and the effect of rapamycin on the growth inhibition and apoptosis induction of K562 cells in vitro. Methods:The mRNA levels of BCR/ABL, PTEN, and mTOR in K562 cells were detected by real-time fluorescent quantitative PCR (RFQ-PCR) after treatment with imatinib mesylate. The protein expression levels of PTEN, Akt, and p-Akt were measured by Western blotting after imatinib mesylate treatment or transfection of recombinated adenovirus-PTEN vector containing green fluorescent protein (Ad-PTEN-GFP) into K562 cells. MTr assay was used to test the effect of rapamycin on the proliferation of K562 cells and flow cytometry (FCM) was performed to evaluate the influence of rapamycin on apoptosis of K562 cells in different adenovirus infected groups. Results:The mRNA expression levels of BCR/ABL and mTOR were down-regulated and the expression of PTEN mRNA was up-regulated after imatinib mesylate interference. The expression of mTOR mRNA was decreased in K562 cells after the cells were transfected with wild type PTEN gene compared with Ad-PTEN-GFP transfection group. Ad-PTEN-GFP transfection combined with rapamycin had synergistic effect in inhibiting the proliferation and promoting apoptosis of K562 ceils. The is inhibitory effect was significantly higher in combined treatment group than that in single treatment groups. Conclusion: PTEN is an upstream regulatory gene of mTOR expression. It could inhibit the expression of mTOR. Rapamycin has sygergistic effects with wild type PTEN in inhibiting the proliferation of K562 cells.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第2期139-144,共6页 Tumor
关键词 白血病 实验性 基因表达调控 基因 PTEN MTOR 细胞 K562 Leukemia,experimental Gene expression regulation Gene, PTEN,mTOR Cell, K562
  • 相关文献

参考文献19

  • 1MYERS M P, STOLAROV JP, ENG C,et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase[ J ]. Proc Natl Acad Sci USA, 1997,94 ( 17 ) : 9052- 9057.
  • 2TAMURA M, GU J, MATSUMOTO K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN [J]. Science, 1998, 280(5369) :1614-1617.
  • 3DAHIA PL, AGUIAR RC, ALBERTA J,et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in hematological malignancies [ J ]. Hum Mol Genet, 1999,8 (2) :185-193.
  • 4YILMAZ O H, VALDEZ R, THEISEN B K, et al. Pten dependence distinguishes hematopoietic stem cells from leukemia-initiating cells[J]. Nature, 2006,441 (7092) : 475-482.
  • 5YANG j, LIU J, ZHENG J, et al. A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia[ J]. Leukemia, 2007, 21 (9): 2072-2074.
  • 6CHEONG JW ,EOM JI,MAENG HY,et al. Phosphatase and tensin homologue phospborylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukemia and associated with poor clinical outeome [ J ]. Br J Haernatol, 2003,122 (3) :454- 456.
  • 7LEUPIN N, CENNI B, NOVAK U, et al. Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukemia (B-CLL) [J]. Br J Haematol, 2003,121(1) :97-100.
  • 8ROMAN-GOMEZ J, JIMENEZ-VELASCO A, JUAN A,et al. Promoter hypemethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia[ J]. Blood, 2004, 8( 104): 2492-2498.
  • 9XU Q, SIMPSON S E, SCIALLA T J,et al. Survival of acute myeloid leukemia ceils requires PI3 kinase activation [ J ]. Blood, 2003, 102 (3) :972-980.
  • 10MARTELLI A M, TAZZARI P L, EVANGELISTI C, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside [ J ]. Curr Med Chem ,2007,14 ( 19 ) :2009-2023.

同被引文献73

  • 1Ye-JiangZhou,Yu-XiaXiong,Xiao-TingWu,DeShi,WeiFan,TongZhou,Yue-ChunLi,XiongHuang.Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer[J].World Journal of Gastroenterology,2004,10(21):3225-3229. 被引量:31
  • 2李艳,王新允,刘婷,朱丛中,孙翠云,王爱香,赵敏,吴兴业.肺癌及癌前病变组织芯片中PTEN的表达及其意义[J].肿瘤,2006,26(1):52-54. 被引量:3
  • 3Gen Tamura.Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer[J].World Journal of Gastroenterology,2006,12(2):192-198. 被引量:107
  • 4KORPAL M,KANG Y.The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis[J].RNA Biol,2008,5(3):115-119.
  • 5HURTEAU G J,CARLSON J A,SPIVACK S D,et al.Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin[J].Cancer Res,2007,67(17):7972-7976.
  • 6ARUMUGAM T,RAMACHANDRAN V,FOURNIER K F,et al.Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer[J].Cancer Res,2009,69(14):5820-5828.
  • 7SELGA E,MORALES C,NO(E) V,et al.Role of caveolin 1,E-cadherin,Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells[J].BMC Med Genomics,2008,1:35.
  • 8SASAKI C Y,LIN H,PASSANITI A.Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis[J].Int J Cancer,2000,86(5):660-666.
  • 9WITTA S E,GEMMILL R M,HIRSCH F R,et al.Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines[J].Cancer Res,2006,66(2):944-950.
  • 10BLACK P C,BROWN G A,INAMOTO T,et al.Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells[J].Clin Cancer Res,2008,14(5):1478-1486.

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部